IGF1 and adrenal cortex carcinoma: As such, before to finally declare a “game over” [47] for the role of IGF2 in adrenocortical tumorigenesis and as potential target for novel treatment in ACC patients, it could be probably useful to return to the bench and try to better explore the IGF pathway in its whole complexity.